Cancer Research Foundation
- Assets
- $10.1m
- Revenue
- $893.7k
- Investments
- $0.0
- Employees
- 1
- Location
- Chicago, IL
- Founding
- 12/2017
- Data as of
- 03/2023
- EIN
- 36-2385213
Organization Overview
Cancer Research Foundation is located in Chicago, IL. The organization was established in 2017. According to its NTEE Classification (H30) the organization is classified as: Cancer Research, under the broad grouping of Medical Research and related organizations. This organization is a parent organization of an affiliated group for tax-exemption purposes. Cancer Research Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 03/2023, Cancer Research Foundation generated $893.7k in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 4.9% each year. All expenses for the organization totaled $1.0m during the year ending 03/2023. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, Cancer Research Foundation has awarded 30 individual grants totaling $7,197,699. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
FUNDING CANCER RESEARCH TO FIND A CURE
Describe the Organization's Program Activity:
Part 3 - Line 4a
GRANTS TO SCIENTISTS AT UNIVERSITY MEDICAL CENTERS FOR CLINICAL AND LABORATORY RESEARCH ON VARIOUS PROJECTS
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Mr S Goldblatt Director | OfficerTrustee | 2 | $0 |
Mr M Cohen President Emeritus | Trustee | 2 | $0 |
Mr J Goldblatt Director | Trustee | 1 | $0 |
Mr M Freed Director | Trustee | 1 | $0 |
Mr T Shields Director | Trustee | 1 | $0 |
Ms L Cohen Schenkman Secretary | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $135,728 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $357,986 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $493,714 |
| Total Program Service Revenue | $0 |
| Investment income | $336,210 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $63,813 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $893,737 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $700,000 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $138,001 |
| Compensation of current officers, directors, key employees. | $27,600 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $440 |
| Payroll taxes | $11,459 |
| Fees for services: Management | $0 |
| Fees for services: Legal | $1,622 |
| Fees for services: Accounting | $24,707 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $78,396 |
| Fees for services: Other | $14,678 |
| Advertising and promotion | $19,727 |
| Office expenses | $9,945 |
| Information technology | $0 |
| Royalties | $0 |
| Occupancy | $939 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,402 |
| All other expenses | $3,073 |
| Total functional expenses | $1,004,389 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $379,918 |
| Savings and temporary cash investments | $0 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $0 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $1,032 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $9,678,870 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $71,256 |
| Total assets | $10,131,076 |
| Accounts payable and accrued expenses | $6,357 |
| Grants payable | $600,000 |
| Deferred revenue | $0 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $33,284 |
| Total liabilities | $639,641 |
| Net assets without donor restrictions | $7,048,549 |
| Net assets with donor restrictions | $2,442,886 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $10,131,076 |
Grants Awarded
Over the last fiscal year, Cancer Research Foundation has awarded $700,000 in support to 4 organizations.
| Grant Recipient | Amount |
|---|---|
UNIVERSITY OF CHICAGO PURPOSE: TO FUND RESEARCH IN EMERGING CANCER THERAPIES/CURES | $400,000 |
WASHINGTON UNIVERSITY IN ST LOUIS PURPOSE: TO FUND RESEARCH IN EMERGING CANCER THERAPIES/CURES | $175,000 |
NORTHWESTERN UNIVERSITY PURPOSE: TO FUND RESEARCH IN EMERGING CANCER THERAPIES/CURES | $100,000 |
HARVARD UNIVERSITY PURPOSE: TO FUND RESEARCH IN EMERGING CANCER THERAPIES/CURES | $25,000 |